ADC Therapeutics SA (NYSE: ADCT) today announced that it has completed a series of strategic transactions in which it:

ADC Therapeutics (NYSE: ADCT) is a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs). The Company is advancing its proprietary ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.



www.adctherapeutics.com

Therapeutics

Adc Therapeutics Announces $175 Million Senior Secured Term Loan From Owl Rock And Oaktree And Settlement Of Existing Senior Secured Convertible Notes

Description

Company Information

Related People

Funding Insights

Adc Therapeutics Announces $175 Million Senior Secured Term Loan From Owl Rock And Oaktree And Settlement Of Existing Senior Secured Convertible Notes

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information